Ropivacaine long-acting injectable - MedinCell
Alternative Names: mdc-CMV; mdc-NVALatest Information Update: 28 Apr 2023
At a glance
- Originator MedinCell S.A.
- Class Anilides; Local anaesthetics; Non-opioid analgesics; Piperidines; Small molecules
- Mechanism of Action Potassium channel antagonists; Sodium channel antagonists
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Anaesthesia; Pain; Postoperative pain
Most Recent Events
- 28 Apr 2023 No recent reports of development identified for preclinical development in Anaesthesia in France (Parenteral, Injection)
- 28 Apr 2023 No recent reports of development identified for preclinical development in Postoperative-pain in France (Parenteral, Injection)
- 28 Feb 2023 No recent reports of development identified for research development in Pain in France (Parenteral, Injection)